An immunochromatographic assay, more commonly called a lateral flow test, is a simple diagnostic device that detects a target substance in a liquid sample by drawing that liquid across a strip of specialized membranes using capillary action. If the target is present, labeled molecules bind to it and accumulate at a specific spot on the strip, producing a visible line. The technology has been in use for roughly six decades and underpins everything from home pregnancy tests to the COVID-19 rapid antigen tests that became a household staple during the pandemic.1PubMed Central. Six decades of lateral flow immunoassay: from determining metabolic markers to diagnosing COVID-19 The underlying principle is straightforward, but the engineering that makes a reliable test from a few cents’ worth of materials is more interesting than it first appears.
What the Strip Is Made Of
A lateral flow test strip is built from four overlapping materials mounted on a plastic backing card. From one end to the other, these are the sample pad, the conjugate pad, the nitrocellulose membrane, and the absorbent pad.2Comprehensive Analytical Chemistry. High yield manufacture of lateral flow test strips: From the lab to the market Each one has a specific job in the chain of events that turns a drop of fluid into a readable result.
The sample pad is typically a piece of filter paper that receives whatever liquid you apply, whether that is a nasal swab extract, a drop of blood, or a urine sample. It often contains buffering chemicals that adjust the pH and salt concentration so the downstream chemistry works properly.2Comprehensive Analytical Chemistry. High yield manufacture of lateral flow test strips: From the lab to the market The conjugate pad sits just downstream and holds dried-down detection molecules, usually gold nanoparticles or colored latex beads coated with antibodies. When the liquid from the sample pad reaches the conjugate pad, it rehydrates those particles and carries them forward. The nitrocellulose membrane is where the action happens: test and control lines are pre-printed here with immobilized capture molecules. Finally, the absorbent pad at the far end acts as a wick, pulling liquid through the entire strip so it does not pool or flow backward.
How the Liquid Moves
The entire test runs on capillary action, the same force that draws water up into a paper towel. No pumps, batteries, or external equipment are needed. The porous structure of the nitrocellulose membrane is central to this: its network of tiny channels pulls the sample forward at a rate determined by pore size, membrane thickness, and surface chemistry. Research has shown that the pore structure along the lateral direction of the membrane governs how fast the bulk liquid advances, while the pore structure through its thickness controls how quickly the target molecules can diffuse inward and react with the capture antibodies.3Journal of Membrane Science. Unveiling the advection-diffusion-reaction mechanism in nitrocellulose membrane for effective lateral flow immunoassay
Getting the flow rate right matters more than you might expect. Too fast and the target molecules do not have enough time to bind at the test line, reducing sensitivity. Too slow and the test takes longer and background signal can build up. Engineers manipulate this by choosing membranes with different pore sizes or by physically altering the strip surface. One study found that simply covering nitrocellulose with tape cut the flow rate to about 60% of its original speed, while the same tape on a synthetic paper substrate more than tripled the rate, because the two materials have very different pore architectures.4PubMed Central. Controlling Capillary Flow Rate on Lateral Flow Test Substrates by Tape That kind of fine-tuning is a big part of what separates a well-performing test from one that gives unreliable results.
How a Visible Line Appears
When you add a sample to a lateral flow test, the liquid first picks up the labeled detection particles from the conjugate pad. If the target substance is in the sample, it binds to the antibodies on those particles as they flow together across the membrane. When this target-particle complex reaches the test line, a second set of antibodies immobilized there grabs the complex and holds it in place. Because millions of colored particles pile up in the same narrow band, a visible line forms. No target in the sample means no complex forms, nothing gets captured, and the test line stays blank.
The control line works similarly but independently. It captures labeled particles regardless of whether any target is present, confirming that the liquid flowed correctly across the membrane and that the reagents are functional. A valid test always shows a control line; if it does not, the test has failed and the result cannot be trusted.
Two Ways to Run the Chemistry
Not every lateral flow test reads the same way. The format described above, where a visible test line means “positive,” is called a sandwich assay. It works well for larger molecules like proteins and viral antigens, where two different antibodies can latch onto different parts of the same target at the same time. Home pregnancy tests, for instance, use this format to detect human chorionic gonadotropin (hCG) in urine.5PubMed Central. A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test
For very small molecules, though, the sandwich approach falls apart. A tiny target does not have enough surface area for two antibodies to bind simultaneously. In these cases, a competitive format is used instead. Here, the sample’s target molecules compete with pre-immobilized molecules at the test line for a limited supply of labeled antibodies. If your sample contains a lot of the target, those antibodies get used up before they reach the test line, so the line is faint or absent. A strong test line actually means the target was not present, or was present in low amounts. This reverse logic can confuse users, but it is necessary for detecting things like drug residues, hormones, and toxic small compounds in food and environmental samples.6PubMed Central. Lateral flow immunoassay for small-molecules detection in phytoproducts: a review One research group developed a competitive lateral flow assay sensitive enough to measure free thyroxine, a thyroid hormone, directly in human serum.7PubMed. Ultrasensitive quantitative detection of small molecules with rapid lateral-flow assay based on high-affinity bifunctional ligand and magnetic nanolabels
What Makes the Color
The classic lateral flow test uses colloidal gold nanoparticles, which appear red or pink to the naked eye. Gold is popular because it is chemically stable, easy to conjugate with antibodies, and produces a strong color signal without any special equipment. But gold nanoparticles have limits when it comes to sensitivity, especially for targets present in very low concentrations.
One approach to boosting the signal involves clustering gold nanoparticles together. A team developing a COVID-19 test created clusters where satellite gold nanoparticles surrounded a core particle, with antibody-based linkers maintaining a gap of over 15 nanometers between them. That gap prevented the particles from changing color (a phenomenon called plasmon coupling) while still multiplying the amount of light absorbed at the test line.8PubMed Central. Plasmon color-preserved gold nanoparticle clusters for high sensitivity detection of SARS-CoV-2 based on lateral flow immunoassay
Quantum dots represent a different strategy altogether. These are nanoscale semiconductor crystals that fluoresce when excited by light. They produce brighter, more stable signals than gold nanoparticles and can be tuned to emit at specific wavelengths, which makes them attractive for tests that need to detect very low levels of a pathogen.9PubMed Central. A New Quantum Dot-Based Lateral Flow Immunoassay for the Rapid Detection of Influenza Viruses The tradeoff is that fluorescent labels require a reader device with an excitation light source, so you lose the “read it with your eyes” simplicity that makes standard lateral flow tests so convenient. Quantum dot-based lateral flow tests have shown particular promise for detecting respiratory viruses when viral loads are low, a scenario where conventional gold-labeled tests sometimes miss infections.10PubMed Central. Recent Advances in Quantum Dot-Based Lateral Flow Immunoassays for the Rapid, Point-of-Care Diagnosis of COVID-19
Where Lateral Flow Tests Are Used
The most familiar application is pregnancy testing, which has been available in over-the-counter form since the 1970s and remains one of the clearest examples of the technology’s strengths: fast, private, cheap, and accurate enough for the purpose.5PubMed Central. A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test But the technology is far more widely deployed than most people realize.
In infectious disease testing, lateral flow assays are used across the globe to detect HIV, malaria, influenza, strep throat, and of course SARS-CoV-2. One evaluation of a rapid immunochromatographic HIV test in Ghana found 100% sensitivity and 100% specificity, with the important practical advantage that the test needed no electricity or running water, making it suitable for rural clinics.11PubMed Central. Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa That combination of reliability and minimal infrastructure requirements is what makes these tests valuable in resource-limited settings.
Outside the clinic, the same basic technology is used to screen food for contamination. Mycotoxins, which are toxic compounds produced by molds that grow on grain and other crops, are a major target. Lateral flow tests can screen bulk food supplies quickly in the field, flagging contaminated batches before they enter the supply chain.12PubMed Central. Recent Advancements in Lateral Flow Assays for Food Mycotoxin Detection: A Review of Nanoparticle-Based Methods and Innovations Newer approaches pair lateral flow strips with surface-enhanced Raman scattering, a technique that amplifies molecular signals, to push sensitivity and accuracy even further in food safety monitoring.13PubMed. The development and application of SERS-based lateral flow immunochromatography in the field of food safety
When These Tests Get It Wrong
Lateral flow tests are designed for speed and convenience, and that comes with known tradeoffs in sensitivity. A standard gold-nanoparticle-based test is not as sensitive as a laboratory PCR test or an ELISA plate assay. At very low target concentrations, there simply are not enough labeled particles captured at the test line to produce a visible band. This is why the COVID-19 rapid tests sometimes returned negative results in people who tested positive by PCR, particularly early in infection when viral loads were still building.
A less intuitive failure mode strikes at the opposite extreme. At very high target concentrations, sandwich-format tests can produce falsely weak or even false-negative results through what is called the hook effect. When there is a huge excess of target molecules, they saturate the labeled antibodies before the complex reaches the test line. Unbound target molecules also compete for the capture antibodies at the test line, and the net result is a paradoxical drop in signal intensity at the very moment the sample is most strongly positive.14PubMed Central. Unraveling the Hook Effect: A Comprehensive Study of High Antigen Concentration Effects in Sandwich Lateral Flow Immunoassays The control line intensity is also affected at high analyte concentrations, which can throw off digital readers that calculate a ratio between the test and control lines.14PubMed Central. Unraveling the Hook Effect: A Comprehensive Study of High Antigen Concentration Effects in Sandwich Lateral Flow Immunoassays In practice, the hook effect is mainly a concern in clinical laboratory settings where samples might contain extremely high analyte levels, such as in some tumor marker assays or certain hormonal conditions.
From Yes-or-No to How-Much
A standard lateral flow test gives a qualitative result: the line is there or it is not. But there is useful information in how dark that line is, because line intensity correlates with how much target substance is in the sample. Extracting that information reliably by eye is impossible, so researchers have turned to digital readers and, increasingly, smartphone cameras to turn lateral flow tests into semi-quantitative or fully quantitative tools.
A simple smartphone-based approach uses the phone camera to photograph the strip and an algorithm to measure the color intensity of the test and control lines. One research group demonstrated a method that maintained high estimation accuracy under varying lighting conditions without needing any additional hardware.15PubMed Central. Analyte Quantity Detection from Lateral Flow Assay Using a Smartphone Dedicated compact strip readers that clip onto a phone or sit on a benchtop have also been developed, pairing the low cost of the strip itself with the processing power of a digital device.16Sensors and Actuators B: Chemical. A simple and compact smartphone-based device for the quantitative readout of colloidal gold lateral flow immunoassay strips This shift toward quantification opens up applications where knowing the concentration matters, such as monitoring drug levels in blood or tracking the trajectory of an infection over time, rather than simply confirming its presence.
Testing for Multiple Targets at Once
A single-target test is fine when you already know what you are looking for, but many clinical and field situations benefit from checking several targets simultaneously. Multiplexed lateral flow tests do this by incorporating multiple test lines on the same strip, each printed with a different capture antibody. Some designs use separate strips bundled in one cassette, while others use branching flow paths or spatially distinct zones on a single membrane.17PubMed. Multiplexed lateral flow biosensors: Technological advances for radically improving point-of-care diagnoses These multiplexed tests are particularly relevant in settings like flu season, when a patient could have influenza A, influenza B, RSV, or COVID-19, and the treatment decision depends on knowing which one.
Alternatives to Antibodies
Nearly all commercial lateral flow tests rely on antibodies as their recognition molecules, but antibodies have drawbacks that matter at scale. They need to be produced in living cells, they are sensitive to temperature, they vary from batch to batch, and the development process is slow and expensive. Aptamers offer a potential workaround. These are short stretches of synthetic DNA or RNA that fold into shapes capable of binding specific targets, much like antibodies do, but they are made entirely through chemical synthesis. That means they can be produced faster, at lower cost, without animal use, and with better consistency between batches.18PubMed Central. Aptamer-Based Lateral Flow Assays: Current Trends in Clinical Diagnostic Rapid Tests Aptamer-based lateral flow tests are not yet widespread in commercial products, but they are under active development and could eventually reduce the cost and expand the shelf life of rapid tests, especially in hot climates where cold-chain storage for antibody-based reagents is difficult.
CRISPR-Powered Lateral Flow
One of the more striking recent developments is the integration of CRISPR gene-editing tools with lateral flow strips. In these assays, CRISPR proteins are used not to edit anything but to detect specific genetic sequences. The CRISPR system is programmed to recognize a target DNA or RNA sequence. When it finds that sequence, it activates and cuts a reporter molecule, and the resulting fragments are then detected on a lateral flow strip. One group demonstrated a CRISPR/Cas9-based lateral flow assay that could detect SARS-CoV-2 sequences with single-base specificity, meaning it could distinguish between viral variants that differ by just one genetic letter.19PubMed Central. CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics This kind of precision goes well beyond what a standard antibody-based lateral flow test can achieve and could eventually enable rapid point-of-care testing for genetic diseases, antibiotic-resistant bacteria, and specific pathogen strains.
Manufacturing at Scale
One reason lateral flow tests became so ubiquitous during the COVID-19 pandemic is that they can be manufactured in enormous volumes once the production infrastructure is in place. Millions of test strips can be produced per month, but scaling up takes significant investment in specialized equipment and time. The lack of manufacturing capacity was a major bottleneck in the global COVID-19 response through much of 2020, even though the test designs themselves were available earlier.20Nature Reviews Bioengineering. Lateral flow test engineering and lessons learned from COVID-19 The manufacturing process involves dispensing reagent lines onto membranes with micrometer-level precision, laminating the various pads together, cutting strips to exact widths, and performing quality control on each production lot. Even small inconsistencies in line placement or reagent concentration can change test performance, so the engineering challenge is less about designing a single working prototype and more about replicating it billions of times with acceptable uniformity.
The Environmental Cost of Disposable Tests
The pandemic-era surge in rapid testing highlighted an environmental question that the diagnostic industry had largely avoided: what happens to billions of single-use plastic test cassettes? Most lateral flow tests are housed in injection-molded plastic casings made from conventional petrochemical-based plastics. These generate substantial waste and carbon emissions across their lifecycle. Alternatives are starting to appear. Card-based housings, like the one used in the Abbott BinaxNOW test, reduce plastic use. Researchers have also proposed designs using bioplastics, cellulose, and recycled materials to lower the environmental footprint.21PubMed Central. Mass of components and material distribution in lateral flow assay kits Whether these greener materials can match the durability and moisture resistance of standard plastics at a competitive cost remains an open question, but the pressure to address test waste is only growing as lateral flow testing expands into more routine health monitoring and food safety screening.